nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes
|
Gladd, Debbie A. |
|
2009 |
11 |
1 |
p. 43-51 |
artikel |
2 |
Aspirin and acetaminophen: Should they be available over the counter?
|
Brune, Kay |
|
2009 |
11 |
1 |
p. 36-40 |
artikel |
3 |
Atherosclerosis in autoimmune diseases
|
Matsuura, Eiji |
|
2009 |
11 |
1 |
p. 61-69 |
artikel |
4 |
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs
|
Hermann, Matthias |
|
2009 |
11 |
1 |
p. 31-35 |
artikel |
5 |
Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system
|
Wahl, Denis |
|
2009 |
11 |
1 |
p. 77-81 |
artikel |
6 |
Neonatal effects of maternal antiphospholipid syndrome
|
Tincani, Angela |
|
2009 |
11 |
1 |
p. 70-76 |
artikel |
7 |
Outcome of aspirin treatment of antiphospholipid antibody-positive patients
|
O’Neil, Kathleen M. |
|
2009 |
11 |
1 |
p. 1-2 |
artikel |
8 |
Renal manifestations of the antiphospholipid syndrome
|
D’Cruz, David |
|
2009 |
11 |
1 |
p. 52-60 |
artikel |
9 |
The biomechanics of osteoarthritis: Implications for therapy
|
Block, Joel A. |
|
2009 |
11 |
1 |
p. 15-22 |
artikel |
10 |
The use of opioids in the treatment of osteoarthritis: When, why, and how?
|
Goodwin, Jeremy L. R. |
|
2009 |
11 |
1 |
p. 5-14 |
artikel |
11 |
WNT signaling in osteoarthritis and osteoporosis: What is the biological significance for the clinician?
|
Lodewyckx, Liesbet |
|
2009 |
11 |
1 |
p. 23-30 |
artikel |